Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Mitchell Kapoor upgraded Kyverna Therapeutics, Inc. (NASDAQ:KYTX) from Neutral to Buy and raised the price target from $4 to $5. Kyverna Therapeutics shares closed at $2.27 on Friday. See how other analysts view this stock.
- Wolfe Research analyst Timna Tanners upgraded the rating for Commercial Metals Company …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Mitchell Kapoor upgraded Kyverna Therapeutics, Inc. (NASDAQ:KYTX) from Neutral to Buy and raised the price target from $4 to $5. Kyverna Therapeutics shares closed at $2.27 on Friday. See how other analysts view this stock.
- Wolfe Research analyst Timna Tanners upgraded the rating for Commercial Metals Company …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Mitchell Kapoor upgraded Kyverna Therapeutics, Inc. (NASDAQ:KYTX) from Neutral to Buy and raised the price target from $4 to $5. Kyverna Therapeutics shares closed at $2.27 on Friday. See how other analysts view this stock.
Wolfe Research analyst Timna Tanners upgraded the rating for Commercial Metals Company …Full story available on Benzinga.com Read MoreBRBR, CMC, CTOR, GMED, KYTX, LFST, MSM, News, RGA, top upgrades, Upgrades, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, CMC, US2017231034, MSM, US5535301064, RGA, US7593516047, GMED, BRBR, LFST, KYTX, CTOR, News, Upgrades, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
